Literature DB >> 22518005

Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement.

Juling Zhou1, Xiaosen Ouyang, Trenton R Schoeb, Subhashini Bolisetty, Xiangqin Cui, Sylvie Mrug, Bradley K Yoder, Martin R Johnson, Alexander J Szalai, Michal Mrug.   

Abstract

AKI accelerates cystogenesis. Because cystogenic mutations induce strong transcriptional responses similar to those seen after AKI, these responses may accelerate the progression of cystic renal disease. Here, we modulated the severity of the AKI-like response in Cys1(cpk/cpk) mice, a model that mimics autosomal recessive polycystic kidney disease. Specifically, we induced or inhibited activity of the renoprotective enzyme heme oxygenase (HO) and determined the effects on renal cystogenesis. We found that induction of HO attenuated both renal injury and the rate of cystogenesis, whereas inhibition of HO promoted cystogenesis. HO activity mediated the response of NFκB, which is a hallmark transcriptional feature common to both cystogenesis and AKI. Among the HO-modulated effects we measured, expression of complement component 3 (C3) strongly correlated with cystogenesis, a functionally relevant association as suggested by Cys1(cpk/cpk) mice with genetically induced C3 deficiency. Because both C3 deficiency and HO induction reduce cyst number and cyst areas, these two factors define an injury-stimulated cystogenic pathway that may provide therapeutic targets to slow the formation of new renal cysts and the growth of existing cysts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22518005      PMCID: PMC3380643          DOI: 10.1681/ASN.2011050442

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  65 in total

1.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

2.  Increased water intake decreases progression of polycystic kidney disease in the PCK rat.

Authors:  Shizuko Nagao; Kazuhiro Nishii; Makoto Katsuyama; Hiroki Kurahashi; Tohru Marunouchi; Hisahide Takahashi; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

Review 3.  The involvement of oxidative stress in the progression of renal injury.

Authors:  E Haugen; K A Nath
Journal:  Blood Purif       Date:  1999       Impact factor: 2.614

4.  Antisense CD11b integrin inhibits the development of a differentiated monocyte/macrophage phenotype in human leukemia cells.

Authors:  Igor Prudovsky; Konstantin Popov; Sergey Akimov; Sergey Serov; Alexander Zelenin; Gerold Meinhardt; Peter Baier; Christoph Sohn; Ralf Hass
Journal:  Eur J Cell Biol       Date:  2002-01       Impact factor: 4.492

Review 5.  Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1.

Authors:  Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-22

6.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

7.  Overexpression of innate immune response genes in a model of recessive polycystic kidney disease.

Authors:  M Mrug; J Zhou; Y Woo; X Cui; A J Szalai; J Novak; G A Churchill; L M Guay-Woodford
Journal:  Kidney Int       Date:  2007-10-24       Impact factor: 10.612

8.  A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.

Authors:  Klaus Piontek; Luis F Menezes; Miguel A Garcia-Gonzalez; David L Huso; Gregory G Germino
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

9.  A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li; Brenda S Magenheimer; Sheng Xia; Teri Johnson; Darren P Wallace; James P Calvet; Rong Li
Journal:  Nat Med       Date:  2008-06-15       Impact factor: 53.440

10.  Abolished adherence alters signaling pathways in phorbol ester-induced human U937 cells.

Authors:  Anna Otte; Katharina Mandel; Gesche Reinstrom; Ralf Hass
Journal:  Cell Commun Signal       Date:  2011-09-22       Impact factor: 5.712

View more
  20 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 3.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

Review 4.  Heme Oxygenase-1 in Kidney Health and Disease.

Authors:  Jeremie M Lever; Ravindra Boddu; James F George; Anupam Agarwal
Journal:  Antioxid Redox Signal       Date:  2016-05-26       Impact factor: 8.401

Review 5.  Primary cilia and kidney injury: current research status and future perspectives.

Authors:  Shixuan Wang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-31

Review 6.  JAK inhibition and progressive kidney disease.

Authors:  Frank C Brosius; John Cijiang He
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

Review 7.  Adaptive responses to tissue injury: role of heme oxygenase-1.

Authors:  Anupam Agarwal; Subhashini Bolisetty
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

8.  STAT3 Signaling in Polycystic Kidney Disease.

Authors:  Thomas Weimbs; Jeffrey J Talbot
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

9.  ERK-mediated suppression of cilia in cisplatin-induced tubular cell apoptosis and acute kidney injury.

Authors:  Shixuan Wang; Qingqing Wei; Guie Dong; Zheng Dong
Journal:  Biochim Biophys Acta       Date:  2013-05-29

Review 10.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.